Essity AB

  • Market Cap: Large Cap
  • Industry: FMCG
  • ISIN: SE0009922164
SEK
247.60
-3.1 (-1.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.77 M

Shareholding (Mar 2026)

FII

0.01%

Held by 2 FIIs

DII

99.99%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Operating profit has grown by an annual rate 1.85% of over the last 5 years

 
2

With ROE of 14.87%, it has a very expensive valuation with a 2.13 Price to Book Value

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

FMCG

stock-summary
Market cap

SEK 173,448 Million (Large Cap)

stock-summary
P/E

14.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

3.21%

stock-summary
Debt Equity

0.34

stock-summary
Return on Equity

14.31%

stock-summary
Price to Book

1.98

Revenue and Profits:
Net Sales:
33,177 Million
(Quarterly Results - Mar 2026)
Net Profit:
2,901 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.19%
0%
-11.19%
6 Months
-7.44%
0%
-7.44%
1 Year
-9.2%
0%
-9.2%
2 Years
-10.81%
0%
-10.81%
3 Years
-18.87%
0%
-18.87%
4 Years
-2.13%
0%
-2.13%
5 Years
-13.94%
0%
-13.94%

Essity AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
2.61%
EBIT Growth (5y)
1.85%
EBIT to Interest (avg)
10.11
Debt to EBITDA (avg)
2.19
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
1.16
Tax Ratio
25.52%
Dividend Payout Ratio
47.63%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
12.85%
ROE (avg)
14.82%

Valuation key factors

Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
2.13
EV to EBIT
11.21
EV to EBITDA
8.12
EV to Capital Employed
1.86
EV to Sales
1.50
PEG Ratio
2.03
Dividend Yield
2.92%
ROCE (Latest)
16.63%
ROE (Latest)
14.87%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.01%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -4.38% vs 0.16% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -10.02% vs -3.99% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "33,177.00",
          "val2": "34,695.00",
          "chgp": "-4.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,938.00",
          "val2": "6,582.00",
          "chgp": "-9.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "28.00",
          "val2": "309.00",
          "chgp": "-90.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-19.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,901.00",
          "val2": "3,224.00",
          "chgp": "-10.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "126.50%",
          "val2": "137.60%",
          "chgp": "-1.11%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -4.85% vs -1.09% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 5.69% vs 26.44% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "138,494.00",
          "val2": "145,546.00",
          "chgp": "-4.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "25,644.00",
          "val2": "26,344.00",
          "chgp": "-2.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1,461.00",
          "val2": "767.00",
          "chgp": "90.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-46.00",
          "val2": "-908.00",
          "chgp": "94.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "12,718.00",
          "val2": "12,033.00",
          "chgp": "5.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "134.30%",
          "val2": "131.60%",
          "chgp": "0.27%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
33,177.00
34,695.00
-4.38%
Operating Profit (PBDIT) excl Other Income
5,938.00
6,582.00
-9.78%
Interest
28.00
309.00
-90.94%
Exceptional Items
0.00
-19.00
100.00%
Consolidate Net Profit
2,901.00
3,224.00
-10.02%
Operating Profit Margin (Excl OI)
126.50%
137.60%
-1.11%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is -4.38% vs 0.16% in Dec 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -10.02% vs -3.99% in Dec 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
138,494.00
145,546.00
-4.85%
Operating Profit (PBDIT) excl Other Income
25,644.00
26,344.00
-2.66%
Interest
1,461.00
767.00
90.48%
Exceptional Items
-46.00
-908.00
94.93%
Consolidate Net Profit
12,718.00
12,033.00
5.69%
Operating Profit Margin (Excl OI)
134.30%
131.60%
0.27%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is -4.85% vs -1.09% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 5.69% vs 26.44% in Dec 2024

stock-summaryCompany CV
About Essity AB stock-summary
stock-summary
Essity AB
FMCG
Essity AB (publ) is a Sweden-based hygiene and health company that develops, produces, markets and sells personal care and tissue products. The Company conducts sales in about 150 countries under such brands, as TENA for incontinence products and Tork for Away-from-Home tissue, as well as under other brands, such as Bodyform, Velvet, Cushelle and Plenty. The Company’s medical brands comprise Leukoplast, Cutimed, JOBST, Delta Cast, Delta Lite and Actimove.
Company Coordinates stock-summary
Company Details
Klarabergsviadukten 63 , STOCKHOLM None : 111 64
stock-summary
Tel: 46 8 788510046 8 7885130
stock-summary
Registrar Details